Starpharma Holdings Ltd SPHRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.10
- Day Range
- $0.09–0.10
- 52-Week Range
- $0.08–0.32
- Bid/Ask
- $0.08 / $0.09
- Market Cap
- $40.83 Mil
- Volume/Avg
- 12,000 / 83,002
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 32
- Website
- https://www.starpharma.com
Comparables
Valuation
|
Metric
|
SPHRF
|
SCLX
|
300142
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 39.39 |
Price/Book Value | 1.74 | — | 2.43 |
Price/Sales | 6.77 | 2.65 | 5.50 |
Price/Cash Flow | — | — | 17.04 |
Price/Earnings
SPHRF
SCLX
300142
Financial Strength
|
Metric
|
SPHRF
|
SCLX
|
300142
|
|---|---|---|---|
Quick Ratio | 5.22 | 0.15 | — |
Current Ratio | 5.60 | 0.19 | — |
Interest Coverage | — | −106.04 | — |
Quick Ratio
SPHRF
SCLX
300142
Profitability
|
Metric
|
SPHRF
|
SCLX
|
300142
|
|---|---|---|---|
Return on Assets (Normalized) | −16.39% | −106.47% | — |
Return on Equity (Normalized) | −22.84% | — | — |
Return on Invested Capital (Normalized) | −23.09% | −1,960.39% | — |
Return on Assets
SPHRF
SCLX
300142
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qkqcbzldg | Xtph | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Tfbqwzrr | Lrhtgk | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bhjrpgnb | Gndhbd | $99.5 Bil | |
MRNA
| Moderna Inc | Qgkgstl | Jtq | $38.8 Bil | |
ARGX
| argenx SE ADR | Npsrbvwy | Klfh | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Hdsjcmyn | Mcjz | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zltwgzzkp | Ydmxghh | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jqwcvjdp | Vmblq | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Sybyvpxdd | Xbylnwl | $12.5 Bil | |
INCY
| Incyte Corp | Gpjhfpzn | Jtcmtg | $11.6 Bil |